{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:06:19Z","timestamp":1772611579579,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Netherlands Organization for Health Research and Development and the Dutch Kidney Foundation."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27815-y","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:45:51Z","timestamp":1766400351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SARS-CoV-2-specific B cell responses in non-draining lymph nodes and antibody functionalities in immunized end-stage renal disease patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Sophie C.","family":"Fr\u00f6lke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daryl","family":"Geers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenney G.","family":"Amirkhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danisha Sri","family":"Pathmarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelly","family":"van der Bom-Baylon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirza M.","family":"Idu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit","family":"van Gils","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Claireaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne E.","family":"Geerlings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"Rispens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory D.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"van Binnendijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester B. M.","family":"Remmerswaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel C.","family":"van Aalderen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederike J.","family":"Bemelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"27815_CR1","doi-asserted-by":"publisher","first-page":"720402","DOI":"10.3389\/fmed.2021.720402","volume":"8","author":"D Ducloux","year":"2021","unstructured":"Ducloux, D. et al. End-Stage renal Disease-Related accelerated immune senescence: is rejuvenation of the immune system a therapeutic goal? Front. Med. (Lausanne). 8, 720402. https:\/\/doi.org\/10.3389\/fmed.2021.720402 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"27815_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003983","author":"JF Sanders","year":"2021","unstructured":"Sanders, J. F. et al. The RECOVAC Immune-response study: the Immunogenicity, Tolerability, and safety of COVID-19 vaccination in patients with chronic kidney Disease, on Dialysis, or living with a kidney transplant. Transplantation https:\/\/doi.org\/10.1097\/TP.0000000000003983 (2021).","journal-title":"Transplantation"},{"key":"27815_CR3","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205\u20131211. https:\/\/doi.org\/10.1038\/s41591-021-01377-8 (2021).","journal-title":"Nat. Med."},{"key":"27815_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.kint.2021.05.011","volume":"100","author":"S Caillard","year":"2021","unstructured":"Caillard, S. et al. Occurrence of severe COVID-19 in vaccinated transplant patients. Kidney Int. 100, 477\u2013479. https:\/\/doi.org\/10.1016\/j.kint.2021.05.011 (2021).","journal-title":"Kidney Int."},{"key":"27815_CR5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1126\/science.abd7728","volume":"370","author":"A Wajnberg","year":"2020","unstructured":"Wajnberg, A. et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science 370, 1227\u20131230. https:\/\/doi.org\/10.1126\/science.abd7728 (2020).","journal-title":"Science"},{"key":"27815_CR6","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","volume":"27","author":"S Feng","year":"2021","unstructured":"Feng, S. et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat. Med. 27, 2032\u20132040. https:\/\/doi.org\/10.1038\/s41591-021-01540-1 (2021).","journal-title":"Nat. Med."},{"key":"27815_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41577-022-00813-1","volume":"23","author":"A Zhang","year":"2023","unstructured":"Zhang, A. et al. Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection. Nat. Rev. Immunol. 23, 381\u2013396. https:\/\/doi.org\/10.1038\/s41577-022-00813-1 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"27815_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41467-023-35815-7","volume":"14","author":"HF Tseng","year":"2023","unstructured":"Tseng, H. F. et al. Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Nat. Commun. 14, 189. https:\/\/doi.org\/10.1038\/s41467-023-35815-7 (2023).","journal-title":"Nat. Commun."},{"key":"27815_CR9","doi-asserted-by":"publisher","unstructured":"Osmanodja, B. et al. Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients. J. Clin. Med. 11 https:\/\/doi.org\/10.3390\/jcm11092565 (2022).","DOI":"10.3390\/jcm11092565"},{"key":"27815_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","volume":"604","author":"W Kim","year":"2022","unstructured":"Kim, W. et al. Germinal centre-driven maturation of B cell response to mRNA vaccination. Nature 604, 141\u2013145. https:\/\/doi.org\/10.1038\/s41586-022-04527-1 (2022).","journal-title":"Nature"},{"key":"27815_CR11","doi-asserted-by":"publisher","unstructured":"Lederer, K. et al. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Cell 185, 1008\u20131024 e1015. https:\/\/doi.org\/10.1016\/j.cell.2022.01.027 (2022).","DOI":"10.1016\/j.cell.2022.01.027"},{"key":"27815_CR12","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3389\/fimmu.2019.02458","volume":"10","author":"I Sanz","year":"2019","unstructured":"Sanz, I. et al. Challenges and opportunities for consistent classification of human B cell and plasma cell populations. Front. Immunol. 10, 2458. https:\/\/doi.org\/10.3389\/fimmu.2019.02458 (2019).","journal-title":"Front. Immunol."},{"key":"27815_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41541-023-00724-9","volume":"8","author":"RGE Krause","year":"2023","unstructured":"Krause, R. G. E. et al. Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells. NPJ Vaccines. 8, 119. https:\/\/doi.org\/10.1038\/s41541-023-00724-9 (2023).","journal-title":"NPJ Vaccines"},{"key":"27815_CR14","doi-asserted-by":"publisher","first-page":"eade2798","DOI":"10.1126\/sciimmunol.ade2798","volume":"8","author":"P Irrgang","year":"2023","unstructured":"Irrgang, P. et al. Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Sci. Immunol. 8, eade2798. https:\/\/doi.org\/10.1126\/sciimmunol.ade2798 (2023).","journal-title":"Sci. Immunol."},{"key":"27815_CR15","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1111\/all.16089","volume":"79","author":"AM Valk","year":"2024","unstructured":"Valk, A. M. et al. Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination. Allergy 79, 1952\u20131961. https:\/\/doi.org\/10.1111\/all.16089 (2024).","journal-title":"Allergy"},{"key":"27815_CR16","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1093\/cid\/ciac557","volume":"76","author":"JF Sanders","year":"2023","unstructured":"Sanders, J. F. et al. Antibody and T-Cell responses 6 months after coronavirus disease 2019 messenger RNA-1273 vaccination in patients with chronic kidney disease, on Dialysis, or living with a kidney transplant. Clin. Infect. Dis. 76, e188\u2013e199. https:\/\/doi.org\/10.1093\/cid\/ciac557 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"27815_CR17","doi-asserted-by":"publisher","first-page":"740708","DOI":"10.3389\/fimmu.2021.740708","volume":"12","author":"A Ciabattini","year":"2021","unstructured":"Ciabattini, A. et al. Evidence of SARS-CoV-2-Specific memory B cells six months after vaccination with the BNT162b2 mRNA vaccine. Front. Immunol. 12, 740708. https:\/\/doi.org\/10.3389\/fimmu.2021.740708 (2021).","journal-title":"Front. Immunol."},{"key":"27815_CR18","doi-asserted-by":"publisher","first-page":"e2204607119","DOI":"10.1073\/pnas.2204607119","volume":"119","author":"L Kardava","year":"2022","unstructured":"Kardava, L. et al. Early human B cell signatures of the primary antibody response to mRNA vaccination. Proc. Natl. Acad. Sci. U S A. 119, e2204607119. https:\/\/doi.org\/10.1073\/pnas.2204607119 (2022).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"27815_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","volume":"596","author":"JS Turner","year":"2021","unstructured":"Turner, J. S. et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 596, 109\u2013113. https:\/\/doi.org\/10.1038\/s41586-021-03738-2 (2021).","journal-title":"Nature"},{"key":"27815_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2711-0","volume":"586","author":"JS Turner","year":"2020","unstructured":"Turner, J. S. et al. Human germinal centres engage memory and Naive B cells after influenza vaccination. Nature 586, 127\u2013132. https:\/\/doi.org\/10.1038\/s41586-020-2711-0 (2020).","journal-title":"Nature"},{"key":"27815_CR21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","volume":"185","author":"K Roltgen","year":"2022","unstructured":"Roltgen, K. et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell 185, 1025\u20131040. https:\/\/doi.org\/10.1016\/j.cell.2022.01.018 (2022). e1014.","journal-title":"Cell"},{"key":"27815_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-021-00657-1","volume":"22","author":"BJ Laidlaw","year":"2022","unstructured":"Laidlaw, B. J. & Ellebedy, A. H. The germinal centre B cell response to SARS-CoV-2. Nat. Rev. Immunol. 22, 7\u201318. https:\/\/doi.org\/10.1038\/s41577-021-00657-1 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"27815_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(06)93001-6","volume":"93","author":"Q Pan-Hammarstrom","year":"2007","unstructured":"Pan-Hammarstrom, Q., Zhao, Y. & Hammarstrom, L. Class switch recombination: a comparison between mouse and human. Adv. Immunol. 93, 1\u201361. https:\/\/doi.org\/10.1016\/S0065-2776(06)93001-6 (2007).","journal-title":"Adv. Immunol."},{"key":"27815_CR24","doi-asserted-by":"publisher","first-page":"1020844","DOI":"10.3389\/fimmu.2022.1020844","volume":"13","author":"JS Buhre","year":"2022","unstructured":"Buhre, J. S. et al. mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine. Front. Immunol. 13, 1020844. https:\/\/doi.org\/10.3389\/fimmu.2022.1020844 (2022).","journal-title":"Front. Immunol."},{"key":"27815_CR25","doi-asserted-by":"publisher","first-page":"13166","DOI":"10.1038\/s41598-023-40103-x","volume":"13","author":"P Kiszel","year":"2023","unstructured":"Kiszel, P. et al. Class switch towards Spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history. Sci. Rep. 13, 13166. https:\/\/doi.org\/10.1038\/s41598-023-40103-x (2023).","journal-title":"Sci. Rep."},{"key":"27815_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","volume":"23","author":"T Rispens","year":"2023","unstructured":"Rispens, T. & Huijbers, M. G. The unique properties of IgG4 and its roles in health and disease. Nat. Rev. Immunol. 23, 763\u2013778. https:\/\/doi.org\/10.1038\/s41577-023-00871-z (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"27815_CR27","doi-asserted-by":"publisher","first-page":"106317","DOI":"10.1016\/j.jinf.2024.106317","volume":"89","author":"AM Marchese","year":"2024","unstructured":"Marchese, A. M. et al. Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccines. J. Infect. 89, 106317. https:\/\/doi.org\/10.1016\/j.jinf.2024.106317 (2024).","journal-title":"J. Infect."},{"key":"27815_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12979-024-00466-9","volume":"21","author":"AT Gelderloos","year":"2024","unstructured":"Gelderloos, A. T. et al. Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adults. Immun. Ageing. 21, 63. https:\/\/doi.org\/10.1186\/s12979-024-00466-9 (2024).","journal-title":"Immun. Ageing"},{"key":"27815_CR29","doi-asserted-by":"publisher","first-page":"eabm7853","DOI":"10.1126\/scitranslmed.abm7853","volume":"14","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty, S. et al. Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Sci. Transl Med. 14, eabm7853. https:\/\/doi.org\/10.1126\/scitranslmed.abm7853 (2022).","journal-title":"Sci. Transl Med."},{"key":"27815_CR30","doi-asserted-by":"publisher","unstructured":"Larsen, M. D. et al. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science 371 https:\/\/doi.org\/10.1126\/science.abc8378 (2021).","DOI":"10.1126\/science.abc8378"},{"key":"27815_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00650-8","author":"MML Kho","year":"2022","unstructured":"Kho, M. M. L. et al. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(22)00650-8 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"27815_CR32","doi-asserted-by":"publisher","unstructured":"van der Putten, C. et al. CD8 and CD4 T cell populations in human kidneys. Cells 10 https:\/\/doi.org\/10.3390\/cells10020288 (2021).","DOI":"10.3390\/cells10020288"},{"key":"27815_CR33","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1182\/blood-2011-09-381574","volume":"119","author":"EB Remmerswaal","year":"2012","unstructured":"Remmerswaal, E. B. et al. Human virus-specific effector-type T cells accumulate in blood but not in lymph nodes. Blood 119, 1702\u20131712. https:\/\/doi.org\/10.1182\/blood-2011-09-381574 (2012).","journal-title":"Blood"},{"key":"27815_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/intimm\/dxt058","volume":"26","author":"SH Havenith","year":"2014","unstructured":"Havenith, S. H. et al. CXCR5\u2009+\u2009CD4\u2009+\u2009follicular helper T cells accumulate in resting human lymph nodes and have superior B cell helper activity. Int. Immunol. 26, 183\u2013192. https:\/\/doi.org\/10.1093\/intimm\/dxt058 (2014).","journal-title":"Int. Immunol."},{"key":"27815_CR35","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.abc5902","volume":"369","author":"PJM Brouwer","year":"2020","unstructured":"Brouwer, P. J. M. et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science 369, 643\u2013650. https:\/\/doi.org\/10.1126\/science.abc5902 (2020).","journal-title":"Science"},{"key":"27815_CR36","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1038\/s41467-022-32232-0","volume":"13","author":"M Claireaux","year":"2022","unstructured":"Claireaux, M. et al. A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 Spike. Nat. Commun. 13, 4539. https:\/\/doi.org\/10.1038\/s41467-022-32232-0 (2022).","journal-title":"Nat. Commun."},{"key":"27815_CR37","doi-asserted-by":"publisher","first-page":"1007016","DOI":"10.3389\/fimmu.2022.1007016","volume":"13","author":"AS Bonavia","year":"2022","unstructured":"Bonavia, A. S., Samuelsen, A., Luthy, J. & Halstead, E. S. Integrated machine learning approaches for flow cytometric quantification of myeloid-derived suppressor cells in acute sepsis. Front. Immunol. 13, 1007016. https:\/\/doi.org\/10.3389\/fimmu.2022.1007016 (2022).","journal-title":"Front. Immunol."},{"key":"27815_CR38","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/infdis\/jiaa479","volume":"222","author":"G den Hartog","year":"2020","unstructured":"den Hartog, G. et al. SARS-CoV-2-Specific antibody detection for seroepidemiology: A multiplex analysis approach accounting for accurate Seroprevalence. J. Infect. Dis. 222, 1452\u20131461. https:\/\/doi.org\/10.1093\/infdis\/jiaa479 (2020).","journal-title":"J. Infect. Dis."},{"key":"27815_CR39","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3201\/eid2607.200841","volume":"26","author":"NMA Okba","year":"2020","unstructured":"Okba, N. M. A. et al. Severe acute respiratory syndrome coronavirus 2-Specific antibody responses in coronavirus disease patients. Emerg. Infect. Dis. 26, 1478\u20131488. https:\/\/doi.org\/10.3201\/eid2607.200841 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"27815_CR40","doi-asserted-by":"publisher","unstructured":"Geers, D. et al. SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. Sci. Immunol. 6 https:\/\/doi.org\/10.1126\/sciimmunol.abj1750 (2021).","DOI":"10.1126\/sciimmunol.abj1750"},{"key":"27815_CR41","doi-asserted-by":"publisher","first-page":"105753","DOI":"10.1016\/j.isci.2022.105753","volume":"26","author":"D Geers","year":"2023","unstructured":"Geers, D. et al. Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination. iScience 26, 105753. https:\/\/doi.org\/10.1016\/j.isci.2022.105753 (2023).","journal-title":"iScience"},{"key":"27815_CR42","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11222-012-9370-4","volume":"24","author":"F Konietschke","year":"2014","unstructured":"Konietschke, F. & Pauly, M. Bootstrapping and permuting paired t-test type statistics. Stat. Comput. 24, 283\u2013296. https:\/\/doi.org\/10.1007\/s11222-012-9370-4 (2014).","journal-title":"Stat. Comput."},{"key":"27815_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10935-009-0191-y","volume":"30","author":"DA Wagstaff","year":"2009","unstructured":"Wagstaff, D. A., Elek, E., Kulis, S. & Marsiglia, F. Using a nonparametric bootstrap to obtain a confidence interval for pearson\u2019s r with cluster randomized data: a case study. J. Prim. Prev. 30, 497\u2013512. https:\/\/doi.org\/10.1007\/s10935-009-0191-y (2009).","journal-title":"J. Prim. Prev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27815-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27815-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27815-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:45:51Z","timestamp":1766400351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27815-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27815"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27815-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44266"}}